Junior Market Analyst
Krka · Milan, Lombardy, Italy
Tailor my CV for this job — freeKrka is one of the leading international generic pharmaceutical companies, with over 70 years of history and more than 12,000 employees worldwide.We manufacture and market prescription and non-prescription medicines, as well as animal health solutions, covering the entire production cycle: from the active ingredient to the finished product, through to validation via clinical trials.Every year, we invest 10% of our turnover in research and development, and our goal is simple and ambitious: to make safe, effective and high-quality medicines accessible to all.ROLE AND RESPONSIBILITIESWe are looking for a new member to join our Marketing team who, reporting to the General Manager, will be responsible for the following activities:Prepare analyses and reviews of marketing and other dataPrepare presentations and reports of processed data to influence strategic choices, correct bad decisions and create personalized actions for usersCreate of BI reporting for the management and the field forceSuggest new models and/or analysis in order to improve efficiency and overall resultsForecasting, segmentation and clusteringMonitor the effectiveness of marketing campaignsRespond to the needs of the different functions in terms of data and modelsWHAT WE VALUESolid Microsoft Office skills, especially with ExcelGoal orientation and ability to work in a teamAnalytical skills and attention to details Proactivity and autonomyFluent EnglishExperience with market analysis, preferably in the pharmaceutical IQVIA platform knowledge is a plusWE OFFERPermanent contract Dedicated development and training programsCompetent, collaborative colleagues with a strong aptitude for teamworkDynamic and international working environmentFlexible working hoursKrka Farmaceutici will process personal data in accordance with current legislation on the protection of personal data, including EU Regulation 2016/679 and Legislative Decree 196/2003 as amended by Legislative Decree 101/2018.